McMaster Perspective

  • COVID-19: October 9 update. Part 2

    COVID-19: October 9 update. Part 2

    Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, comments on the current treatment options in COVID-19.

  • COVID-19: October 9 update. Part 1

    COVID-19: October 9 update. Part 1

    Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, discusses the epidemiologic situation in Belgium and current standards of care for ICU patients with COVID-19.

  • COVID-19: Droplets, aerosols, and masks

    COVID-19: Droplets, aerosols, and masks

    Dr Mark Loeb, professor in the Department of Pathology and Molecular Medicine at McMaster University, joins Dr Roman Jaeschke to clarify the difference between droplets vs aerosols and surgical masks vs N95 respirators.

  • COVID-19: September 10 update. Part 2

    COVID-19: September 10 update. Part 2

    Dr Dominik Mertz, associate professor in the Division of Infectious Diseases at McMaster University and medical director of infection prevention and control at Hamilton Health Sciences, talks about COVID-19 vaccines, reopening schools, and air travel during the pandemic.

  • COVID-19: September 10 update. Part 1

    COVID-19: September 10 update. Part 1

    Dr Dominik Mertz, associate professor in the Division of Infectious Diseases at McMaster University and medical director of infection prevention and control at Hamilton Health Sciences, talks about the current COVID-19 situation worldwide.

  • Heart failure treatment: A decade of progress

    Heart failure treatment: A decade of progress

    Dr Harriette Van Spall, associate professor in the Division of Cardiology at McMaster University, scientist at the Population Health Research Institute, and cardiologist at Hamilton Health Sciences, puts in context some of the most impactful heart failure clinical trials of recent years.

  • Heart failure treatment: The evolution of vasodilators

    Heart failure treatment: The evolution of vasodilators

    Dr Harriette Van Spall, associate professor in the Division of Cardiology at McMaster University, scientist at the Population Health Research Institute, and cardiologist at Hamilton Health Sciences, discusses the evolution of vasodilators used in heart failure treatment.

  • Depression: Explaining CBT

    Depression: Explaining CBT

    Dr Zainab Samaan, associate professor in the Department of Psychiatry and Behavioral Neurosciences at McMaster University, talks about cognitive behavioral therapy (CBT) and the role of therapist-delivered and self-help programs to deal with mood disorders.

  • Heart failure treatment: SGLT-2 inhibitors

    Heart failure treatment: SGLT-2 inhibitors

    Dr Harriette Van Spall, associate professor in the Division of Cardiology at McMaster University, scientist at the Population Health Research Institute, and cardiologist at Hamilton Health Sciences, answers questions about the role of SGLT-2 inhibitors in heart failure treatment.

  • Depression: Choosing pharmacologic treatments

    Depression: Choosing pharmacologic treatments

    Dr Zainab Samaan, associate professor in the Department of Psychiatry and Behavioral Neurosciences at McMaster University, offers an expert overview of the currently available pharmacologic treatments of depression.

125 articles - page 1 of 13

We would love to hear from you

  • Do you have any comments?
  • Have you found a mistake?
  • Would you like to suggest a feature?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.